• 3 years ago
Around the world, COVID vaccines are working well to reduce rates of severe disease and death. But some studies suggest their ability to protect people from milder illness and asymptomatic infections is waning with time.

Category

📺
TV

Recommended

1:41
I
Up next
COVID-19 vaccines — a lot left to do
DW (English)
0:38
Scientists Want To Repurpose Polio Vaccine To Battle COVID-19
Wochit
1:43
What You Need To Know About The New Coronavirus Vaccine
Viraly-Stories
1:10
Researchers identify targets for COVID-19 vaccine using cancer immunotherapy tools
Deccan Herald
1:55
FUN-MOOC : Vaccinology session 3
france-universite-numerique
1:03
Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines - Worldwide Analysis
RenubResearch
2:41
COVID-19 vaccine to become fastest made in history; nine candidates in final stage of trials
Arirang News
2:44
Australian-led research makes flu vaccine discovery
ABC NEWS (Australia)
3:20
Kent expert says testing and vaccine sites are needed to curb coronavirus spread
KentOnline / KMTV
2:16
Oxford's COVID-19 vaccine shows promising immune response in human trials
Arirang News
5:29
Results from largest study into COVID vaccine side effects released
ABC NEWS (Australia)
0:32
Flu Vaccine May Lower Risk Of Severe Illness From COVID-19
Wochit Entertainment
1:53
World's largest study of COVID-19 vaccine side effects
Australian Community Media
7:03
All you need to know about COVID-19 vaccine for children
Aaj Tak
0:52
FDA approves first-ever vaccine to combat severe RSV
Benzinga
1:23
25 Million Kids Missed Routine Vaccinations Because Of COVID-19: United Nations
The Indian Express
1:55
Parents of toddler who died from meningococcal disease campaign for childhood immunisation amid vaccine hesitancy
ABC NEWS (Australia)
2:54
Calls for clearer communication on AstraZeneca vaccine
ABC NEWS (Australia)
2:07
Elderly, frontline workers should be vaccinated first: AIIMS Director
Deccan Herald
1:25
Will We Need to Vaccine Against Covid-19 More Than Once? 
Viraly-Stories
3:11
Covaxin Phase 3 Interim Trial Data: Results Show 81% Efficacy Rate, Claims Bharat Biotech
LatestLY
2:14
Pfizer-BioNTech COVID-19 vaccine shows 90% efficacy for kids aged 5 to 11 – FDA
Manila Bulletin
2:13
Only 2~3% of recovered patients generate antibody for COVID-19: Research
Arirang News
2:55
US CDC Guidelines For Those Fully Vaccinated Against COVID-19: Here Is What You Can & Cannot Do After Getting A COVID-19 Vaccine
LatestLY
3:53
Vaccinating children considered critical step
ABC NEWS (Australia)